Biofrontera AG: Biofrontera AG reports result of the capital increase resolved on April 07, 2022

Leverkusen, Germany (pta024/11.11.2022/18:10 UTC+1)

The shareholders' meeting of Biofrontera AG on April 07, 2022 resolved to increase the share capital of the Company by up to EUR 7,089,673 by issuing up to 7,089,673 new registered no-par value shares with a notional interest in the share capital of EUR 1.00 each ("New Shares") against cash contributions.

According to today's results, a total of 7,089,673 new shares were placed at a subscription price of EUR 1.00 each. Subscription rights were exercised for at least 6.9 million New Shares. The offer has been oversubscribed.

The gross proceeds therefore amount to EUR 7,089,673. The execution of the capital increase will be filed for registration in the Commercial Register shortly.

The funds from the capital increase should enable the Company to advance its strategic business development and market penetration as fast as possible.

(end)

Emitter:	Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany
Contact Person:	Investor Relations
Phone:	+49 (0) 214 87 63 20
E-Mail:	ir@biofrontera.com
Website:	www.biofrontera.com
ISIN(s):	DE0006046113 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate
Other Stock Exchanges:	US OTC